AXA IM and BNPP AM are progressively merging and streamlining our legal entities to create a unified structure. Whilst this is ongoing, we will continue to operate two separate websites both branded BNPP AM. Learn more

The innovation frontier: The significance of patent data for investors

KEY POINTS

Company patents are a compelling investment research resource, offering comprehensive information about a firm’s innovation capabilities
These rich and complex datasets can be both a valuable indicator of future growth potential and a useful tool for investors in making asset allocation decisions
Presently emerging markets are leading the innovation drive, highlighting the potential for attractive investment opportunities

Among the key factors driving company growth and transformation, the one that typically stands head and shoulders above everything else is innovation. And innovation is pervasive across all sectors, business models, geographic regions, and customer bases.

How a company innovates can provide deep insights into future performance, helping investors improve their assessment of its potential. When a firm innovates or invents, it will often file a patent, to protect its legal rights to that idea – and the patent dataset is a compelling research resource. It offers comprehensive information on a company’s innovative activities, which can serve as a valuable indicator of future success across various industries and markets.

The patent dataset that we use is the largest we have ever handled, covering over 37 million entities, containing millions of pages of detailed filings, with each patent averaging around 50 pages. Processing such an immense volume of complex textual data presents significant computational challenges and requires leveraging recent breakthroughs in computing power to efficiently read, analyse, and extract meaningful insights. The advent of large language models further enables us to interpret and evaluate companies’ innovation level relative to their peers, transforming what would have been an otherwise insurmountable data processing task into a feasible analytical process that can help in making investment decisions.

Here, we look at the number of patent filings across time and geographies - focusing on the macro perspective, merely scratching the surface of the depth of information available. 


China overtaking the US

Exhibit 1, below, illustrates patent filings in emerging markets versus developed markets as a percentage of the total each year. It conveys a powerful message: innovation growth has shifted dramatically towards emerging markets, with an observable acceleration of this trend in the mid-2000s. 


Exhibit 2, below, depicts patent filings by the US and China as a percentage of their combined total. During the early 2000s, the US was dominant, but in the 2010s, China began filing extensively. Today, China accounts for approximately 80% of the combined filings between the two countries, reflecting a significant shift in the landscape of innovation.


From Exhibit 2 it is evident that the US alone can’t compete with China in patent activity, so in Exhibit 3 we explore whether the US and Japan or European countries could together overtake China in terms of patent filings. 


Exhibit 4, below, shows patent filings by each country as a percentage of the total filings by year. Several key insights can be gleaned from this chart. Notably, China has significantly transformed its patent landscape, particularly through technological advancement, and now dominates the number of new filings each year. Japan, on the other hand, shows a steep decline in filings, possibly due to the maturation of the domestic market and a shift in corporate research and development investments. The US has maintained its level of innovation activity but appears to have lost some ground, while Germany and France exhibit signs of stagnation. 


Investment implications

For investors, the primary takeaway is the growing significance of China and other emerging market countries in driving innovation. This trend highlights the potential for groundbreaking developments originating from China and presents potential attractive opportunities for returns in the region. 

China has caught up and exceeded the West in patent filings, while India lags due to a combination of factors. These include the lack of sufficient manpower to process patents, low private sector research and development spending, a largely service economy, as well as a stricter patentability criterion where India’s Patent Act has higher bars for patenting than the West. This is particularly visible in the pharmaceutical and software industries, to prevent so-called ‘evergreening’ (a practice that can delay generic competition) and protect public interest. As countries continue to support the commercialisation of their innovation pipeline, there may be yet greater gains to be had in emerging market economies.

While evaluating the volume of patent filings provides a useful measure of innovation, we can also assess the uniqueness and quality of innovation relative to peer companies. Using a proprietary model that combines Large Language Models with graph theory, we aim to identify innovative firms poised for significant growth that have the potential to become the market leaders. For investors, this can highlight potential investment opportunities and offer valuable insights for asset allocation decisions across markets. 

    Disclaimer

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of BNP PARIBAS ASSET MANAGEMENT Europe or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ.

    AXA IM and BNPP AM are progressively merging and streamlining our legal entities to create a unified structure

    AXA Investment Managers joined BNP Paribas Group in July 2025. Following the merger of AXA Investment Managers Paris and BNP PARIBAS ASSET MANAGEMENT Europe and their respective holding companies on December 31, 2025, the combined company now operates under the BNP PARIBAS ASSET MANAGEMENT Europe name.

    Back to top